CMND and SPRC Related Headlines
Go Back- Clearmind Medicine files Hong Kong patent for depression therapy combo
- Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
- Clearmind Medicine receives international patent for weight loss therapy
- Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
- SciSparc files Israeli patent for depression treatment combination therapy
- SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
- Clearmind Medicine files Israeli patent for depression treatment
- Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
- SciSparc and Clearmind publish patent application for binge disorders
- Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
- SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
- Clearmind Medicine receives patent publication for obesity therapy
- SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
- Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
- Clearmind Medicine files patent for obesity and liver disease therapy
- Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
- SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
CMND and SPRC Related Press Releases
Go Back- Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
- Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
- SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
- Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
- Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
- SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders
- Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
- SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
- Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
- SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
